The India bioreactors market is expected to reach US$ 164.8 Mn in 2027 from US$ 94.6 Mn in 2018. The market is estimated to grow with a CAGR of 6.6% from 2019-2027.
The growth of the bioreactors market is primarily attributed to the increasing number of bioreactors manufacturers, speedy evolution of pharmaceutical industry and aggressive pharmaceutical & biotechnological activities. However, concern of regulatory framework is likely to hinder the growth of the market during the forecast period. Additionally, the growth of the India bioreactors market is contributed by factors such as opportunities to develop personalized medicine. India is counted among the emerging nations where the biotechnology and pharmaceutical industry is growing rapidly. According to the Department for Promotion of Industry and Internal Trade Indian biotechnology industries is among the top 12 biotech destinations in the world and ranks third in the Asia Pacific.
